BACKGROUND: Using the newer lower limit of normal criterion instead of the conventional cutoff values to define pulmonary function abnormalities may result in different predictors of pulmonary function impairment in patients with heart failure. Therefore, we assessed predictors of pulmonary function impairment in subjects with chronic heart failure according to the lower limit of normal in comparison with conventional cutoff values. METHODS: In this prospective cross-sectional study, 164 chronic heart failure subjects (age 68 ؎ 10 y, 78% men, 88% New York Heart Association class I-II) with left ventricular ejection fraction <40% underwent pulmonary function tests. Predictors of pulmonary function impairment were assessed using the lower limit of normal and conventional cutoff values (ie, 80% predicted value and the fixed ratio of FEV 1 /FVC <0.7). RESULTS: The lower limit of normal criterion identified an extra independent predictor of diffusion impairment compared with the 80% predicted value; in addition to body mass index, pack-years, and alveolar volume, female sex also turned out to be an independent predictor. A smoking history of >10 pack-years was a significant predictor of diffusion impairment and airway obstruction using the lower limit of normal criterion but not using the conventional cutoff values. However, lowering the cutoff points of conventional criteria to match the more stringent lower limit of normal and thus avoid overdiagnosis of diffusion impairment and airway obstruction in the elderly produced similar results as the lower limit of normal. 
Introduction
Isolated or combined pulmonary function abnormalities, such as restriction, diffusion impairment, and to a lesser extent airway obstruction are common in patients with chronic heart failure [1] [2] [3] [4] [5] [6] [7] and can contribute to the perception of dyspnea 8 and exercise intolerance. [8] [9] [10] [11] [12] Several factors have been implied to play a role in the etiology of pulmonary function impairment in patients with heart failure, including the effects of heart failure itself on pulmonary function in addition to (previously undiagnosed) underlying pulmonary disease and confounding influences, such as smoking, coronary artery bypass grafting, and obesity. [4] [5] [6] [7] 13 However, results are not consistent among the studies. For example, although smoking and a history of coronary artery bypass grafting were associated with more impaired pulmonary function in the study of Johnson et al, 13 with also weak associations between left ventricular function and both lung volumes as well as diffusing capacity, none of the described pulmonary function abnormalities were found to be related to either smoking status, use of cardiac drugs, chest radiographic changes, hemodynamic findings, or clinical features, including the duration of heart failure in the study of Wright et al. 14 Misdiagnosis of pulmonary function abnormalities may have interfered with the interpretation of prior research aiming to investigate the impact of heart failure and several clinical variables on pulmonary function in this group of patients. Traditionally, the 80% predicted value and the fixed ratio of FEV 1 /FVC Ͻ0.7 have been used to define pulmonary function abnormalities. However, these conventional cutoff values have neither statistical nor physiological validity [15] [16] [17] and may misclassify Ͼ20% of patients, leading to false-positive diagnosis in the elderly and underdiagnosis in younger patients. 18 To avoid misclassification, recent American Thoracic Society/European Respiratory Society guidelines 16 recommend the use of statistically derived lower limit of normal values that are based on the normal distribution and that classify the bottom 5% of the healthy population as abnormal. However, studies using the lower limit of normal to assess predictors of pulmonary function impairment in patients with chronic heart failure are lacking. Therefore, the purpose of this study was to assess predictors of pulmonary function impairment in subjects with chronic heart failure according to the lower limit of normal in comparison with conventional cutoff values (percent of predicted and the fixed ratio of FEV 1 /FVC).
Methods

Study Design and Participants
This study was part of a larger prospective cross-sectional study evaluating the prevalence of COPD in subjects with chronic heart failure. All patients visiting 2 outpatient cardiology departments of a large hospital in The Netherlands were screened for inclusion between October 2009 and December 2010. Inclusion criteria were chronic heart failure 19 with left ventricular systolic dysfunction (ie, left ventricular ejection fraction Ͻ40%) and New York Heart Association (NYHA) class I-IV. Chronic heart failure was defined according to the European Society of Cardiology guidelines. 19 Echocardiography was performed in subjects without a recent (Յ6 months) test to confirm persisting left ventricular systolic dysfunction. Subjects who were not able to cooperate or undergo spirometry or who had a history of asthma were excluded. Other exclusion criteria were malignancy with a poor prognosis (survival Ͻ6 months) and participation in another study. For the current study, we also excluded subjects with known pulmonary (including COPD), pleural (with the exception of pleural effusion due to heart failure), neuromuscular, collagen vascular, or other diseases that could affect pulmonary function. Subjects with a body mass index (BMI) Ͼ35 were excluded from the restriction prevalence analysis. The study was approved by the regional Research Ethics Committee Arnhem-Nijmegen in The Netherlands (2009/101, NL27798.091.09) and complied with the Declaration of Helsinki. All subjects gave written informed consent.
Subjects were classified as having stable heart failure in the absence of hospitalization due to progression of heart failure within 3 months, change in diuretics within 1 month, 3% or more weight gain within 3 d, and Ͼ50% increase of N-terminal pro-B natriuretic peptide (NT-proBNP) within
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Current knowledge
Isolated or combined pulmonary function abnormalities are common in patients with chronic heart failure. Traditionally, the 80% predicted value and a fixed ratio of FEV 1 /FVC Ͻ0.7 have been used to define pulmonary function abnormalities. However, compared with the newer lower limit of normal criterion, these conventional cutoff values may misclassify Ͼ20% of patients, leading to false-positive diagnosis in the elderly and underdiagnosis in younger patients. Misdiagnosis of pulmonary function abnormalities may have interfered with the search for predictors of pulmonary function impairment in patients with chronic heart failure.
What this paper contributes to our knowledge
The lower limit of normal identified more predictors of diffusion impairment and airway obstruction compared with conventional cutoff values in subjects with chronic heart failure with left ventricular systolic dysfunction. The lower limit of normal identified sex as an extra predictor of diffusion impairment and a smoking history of Ն10 pack-years as an additional predictor of both diffusion impairment and airway obstruction. Lowering the conventional cutoff points yielded similar results as the lower limit of normal.
1 month when the baseline NT-proBNP was 100 pmol/L or higher or Ͼ100 pmol/L increase of NT-proBNP within 1 month when baseline NT-proBNP was below 100 pmol/L. 20 
Measurements and Data Collection
At baseline, a first blood sample was taken for the measurement of NT-proBNP. One month later, the participants visited the hospital for an interview with the investigator and several examinations, including height and weight measurement, pulmonary function tests, a chest radiograph, and a second blood sample (hemoglobin, NT-proBNP). Additional data were collected from medical records and personal interviews. Smoking status was defined as never (Ͻ100 cigarettes in a lifetime), former (Ն3 months ago), or current smoker (Ͻ3 months ago). Smoking pack-years were based only on the tobacco cigarette history, and 1 pack-year was defined as smoking 20 cigarettes/d for 1 y. Dyspnea was defined as resting dyspnea or dyspnea at any level of exertion.
Pulmonary Function Tests
All participants underwent pre-bronchodilator spirometry (MasterLab Pro, Jaeger, Würzburg, Germany) and measurement of diffusing capacity of the lungs for carbon monoxide (D LCO c). D LCO was measured with the standard single-breath technique and was corrected for the subject's hemoglobin concentration (D LCO c). During the measurement of D LCO , the alveolar volume (V A ) was also obtained, and the D LCO c was corrected for the V A (D LCO c/V A ) (ie, transfer coefficient for carbon monoxide). Body plethysmography was performed in subjects with airway obstruction according to either definition to assess the presence of hyperinflation. In addition, it was performed in subjects with signs of restriction on spirometry (ie, [F]VC Ͻlower limit of normal and/or Ͻ80% predicted with normal FEV 1 /[F]VC ratio) to confirm suspected restriction by measuring the total lung capacity (TLC). In other cases, body plethysmography was omitted, since abnormal findings of body plethysmography were not expected with normal spirometry results. Pulmonary function tests were performed by trained and certified operators using standard techniques and according to the European Respiratory Society standards for acceptability and reproducibility. 21 The European Community for Coal and Steel reference equations were used to calculate predicted values. 21 Diffusion impairment was defined as D LCO c Ͻlower limit of normal (American Thoracic Society/European Respiratory Society) 16 and Ͻ80% predicted (conventional cutoff value). Restriction was defined as TLC Ͻlower limit of normal (American Thoracic Society/European Respiratory Society) 16 and Ͻ80% predicted (conventional cutoff value). Airway obstruction was defined as FEV 1 /VC Ͻlower limit of normal (American Thoracic Society/European Respiratory Society) 16 and FEV 1 /FVC Ͻ0.7 (conventional cutoff value). 22 VC was regarded as the largest vital capacity (either slow, forced, inspiratory, or expiratory). The lower limit of normal was regarded as the lower 5th percentile of the frequency distribution of a healthy reference population, and it was calculated by subtracting 1.64 times the residual SD from the predicted value (Table 1) . Hyperinflation was defined as the absolute ratio of residual volume to TLC Ͼ40%. 23 
Chest Radiographs
Standard posterior-anterior and lateral chest radiographs were performed and evaluated for the presence or absence of cardiomegaly (cardiothoracic ratio Ͼ0.5), congestion (alveolar edema, pleural effusion, Kerley-B lines, and/or redistribution of pulmonary blood flow), and conditions that belonged to the exclusion criteria. Independent radiologists qualitatively assessed the chest radiographs with an overall clinical impression.
Statistical Analysis
Descriptive data are presented as the mean Ϯ SD or as n (%). Differences in the prevalence of pulmonary function abnormalities according to different definitions were analyzed with the McNemar test, which compares paired proportions. Differences between groups were analyzed using an independent t test for continuous variables and a chi-square or Fisher exact test for categorical variables, as appropriate. Differences in pulmonary function between groups of subjects according to NYHA class were ana- lyzed with an independent analysis of variance. Post hoc analyses were performed using the Fisher least-significant difference test when the assumption of homogeneity of variance was met. The least-significant difference pairwise comparison is equivalent to performing multiple t tests on the data. However, it requires the overall analysis of variance to be significant, and therefore the type-1 error is limited to a maximum of 5%. The Games-Howell test was used when the assumption of homogeneity of variance was not met, and it was chosen because of unequal sample sizes. Univariate and multivariate logistic regression analysis was performed to identify independent predictors of diffusion impairment according to different definitions. All variables of interest with a univariate P Ͻ.05 were included in the multivariate analysis. Statistical analyses were performed using SPSS 21.0 (SPSS, Chicago, Illinois). All statistical tests were 2-sided, and P Ͻ.05 was considered significant.
Results
Subject Characteristics
After screening of the entire heart failure population, a cohort of 164 chronic heart failure subjects was selected for the current study, of whom 78% were men ( Table 2 ). The mean age was 68 Ϯ 10 y, and the mean left ventricular ejection fraction was 28 Ϯ 7%. Seventeen percent were in NYHA class I, 71% in NYHA class II, and 12% in NYHA class III. The majority had stable chronic heart failure (86%) without signs of congestion on chest radiograph (89%). Other subject characteristics and results of pulmonary function tests are presented in Tables 2 and 3 , respectively. 
Data are presented as the mean Ϯ SD or as n (%). BMI ϭ body mass index LVEF ϭ left ventricular ejection fraction NYHA ϭ New York Heart Association PCI ϭ percutaneous coronary intervention CRT/ICD ϭ cardiac resynchronization therapy/implantable cardioverter defibrillator ACE-I/ARB ϭ angiotensin-converting enzyme inhibitor/angiotensin receptor blocker NT-proBNP ϭ N-terminal pro-B natriuretic peptide 
Data are presented as the mean Ϯ SD (percent predicted Ϯ SD). Pulmonary function data, with the exception of FEV 1 /VC, are expressed as absolute values and percent predicted based on age, height, and sex. * Reasons for performing body plethysmography: airway obstruction (n ϭ 58), signs of restriction (n ϭ 5), signs of mixed pulmonary dysfunction (n ϭ 7). VC ϭ largest vital capacity D LCO c ϭ diffusing capacity for carbon monoxide corrected for hemoglobin concentration V A ϭ alveolar volume TLC ϭ total lung capacity RV ϭ residual volume ITGV ϭ intrathoracic gas volume R aw ϭ airway resistance sG aw ϭ specific airway conductance
Reliable diffusion measurement could not be obtained in 11 subjects. These subjects were included only in the airway obstruction and restriction prevalence analysis. Similarly, reliable body plethysmography results could not be obtained in 3 subjects. Two of these subjects were consequently excluded from the restriction prevalence analysis, because suspected restriction on spirometry could not be confirmed by reliable body plethysmography results. Nine subjects had a BMI of Ͼ35 and were subsequently excluded from the restriction prevalence analysis.
Pulmonary Function Impairment
Prevalence rates of pulmonary function impairment are shown in Table 4 . The most noted pulmonary function abnormality was diffusion impairment, which was more prevalent using the conventional cutoff value of 80% predicted instead of the lower limit of normal (58% vs 44%, respectively; P Ͻ .001). The second most prevalent abnormality was airway obstruction, which was more frequent using the fixed ratio of 0.7 instead of the lower limit of normal (37% vs 26%, respectively; P ϭ .002). In contrast to the high occurrence of diffusion impairment and airway obstruction, restriction was infrequent, irrespective of the definition used (5% vs 7%, respectively; P ϭ .25). This was also true when the 2 subjects with suspected restriction on spirometry but without a reliable body plethysmography result to confirm this were regarded as having restriction (7% vs 8%, respectively; P ϭ .25). Hyperinflation was present in 46% of 65 subjects with airway obstruction or signs of mixed pulmonary dysfunction on spirometry who performed body plethysmography. The definition used for airway obstruction did not impact the occurrence of hyperinflation.
The frequency of pulmonary function abnormalities according to either definition was not significantly different between current/former smokers and non-smokers. However, subjects who had smoked Ն10 pack-years had diffusion impairment and airway obstruction more often compared with those with Ͻ10 pack-years using the lower limit of normal (51% vs 35% and 31% vs 17%, respectively; P ϭ .05). The significance of this relationship was lost when using conventional cutoff values (62% vs 50% [P ϭ .14] and 40% vs 33% [P ϭ .35], respectively). On the other hand, lowering the conventional cutoff value to 75% for diffusion impairment (D LCO c Ͻ 75% predicted) and 0.65 for airway obstruction (FEV 1 /FVC ratio Ͻ 0.65) yielded significant differences in the occurrence of diffusion impairment and airway obstruction when comparing groups of subjects who had smoked Ն10 pack-years versus Ͻ10 pack-years (51% vs 33% [P ϭ .03] and 27% vs 9% [P ϭ .01], respectively). The frequency of airway obstruction according to either definition was not significantly different between men and women (lower limit of normal: 27% vs 19%, respectively, P ϭ .34; fixed ratio of 0.7: 41% vs 25%, respectively, P ϭ .09). However, although the frequency of diffusion impairment according to the 80% predicted value was not significantly different between men and women (54% vs 70%, respectively; 
, women had diffusion impairment significantly more often than men using the lower limit of normal (61% vs 40%, respectively; P ϭ .04). Lowering the conventional cutoff value to 70% (D LCO c Ͻ70% predicted) yielded significant differences between women and men in the occurrence of diffusion impairment (58% vs 33%, respectively; P ϭ .01). Subjects with a higher NYHA class had lower FEV 1 , D LCO c, and V A (Table 5) . Subjects who had smoked Ն10 pack-years had lower FEV 1 , FEV 1 /VC ratio, and D LCO c than those with Ͻ10 pack-years (Table 6 ). Subjects with pulmonary congestion, pleural effusion, or cardiomegaly on chest radiograph had lower lung volumes and diffusing capacity than those without pulmonary congestion, pleural effusion, or cardiomegaly (Table 7) . D LCO c corrected for V A , however, was comparable between the groups. A history of coronary artery bypass grafting was associated with lower lung volumes.
Univariate and Multivariate Logistic Regression Analysis
Since the most frequently observed abnormality in pulmonary function was diffusion impairment, we performed a univariate and multivariate logistic regression analysis to identify independent predictors of diffusion impairment according to different definitions (Table 8 ). All variables of interest with a univariate P Ͻ .05 were included in the multivariate analysis. These included female sex, BMI, pack-years, NT-proBNP, and V A to identify independent predictors of diffusion impairment according to the lower limit of normal. In addition, BMI, cardiomegaly, packyears, NT-proBNP, and V A were included to identify independent predictors of diffusion impairment according to the 80% predicted value. Multivariate analysis showed female sex, BMI, pack-years (continuous variable), and V A to be independent predictors of diffusion impairment according to the lower limit of normal. Similar variables were found to be associated with diffusion impairment according to the 80% predicted value, except for female sex. However, female sex became an independent predictor of diffusion impairment after lowering the conventional cutoff value to 70% (D LCO A smoking history of Ն10 pack-years was a significant predictor of airway obstruction (univariate logistic analy- 
Discussion
The current study showed that the definition used for pulmonary function impairment impacts the role of sex and smoking in pulmonary function in subjects with chronic heart failure with left ventricular systolic dysfunction. The lower limit of normal criterion identified an extra independent predictor of diffusion impairment compared with the 80% predicted value; in addition to BMI, pack-years, and V A , female sex also turned out to be an independent predictor. A smoking history of Ն10 pack-years was a significant predictor of diffusion impairment and airway obstruction using the lower limit of normal criterion but not using the conventional cutoff values. However, making the conventional cutoff values more stringent by lowering the cutoff point yielded similar results as the lower limit of normal. Lower lung volumes were found in subjects with pulmonary congestion, cardiomegaly, and a history of coronary artery bypass grafting.
In the current study, the conventional cutoff values classified more subjects as having diffusion impairment and airway obstruction compared with the lower limit of normal. This is explained by the physiological decrease of the FEV 1 /FVC ratio with age. The FEV 1 declines more rapidly with age than the FVC in normal subjects. 24 As a result, the fixed ratio of 0.7 that is traditionally used because of its simplicity may lead to overdiagnosis in the elderly and underdiagnosis in younger patients. 18 Furthermore, the frequently used 80% predicted value has neither statistical nor physiological validity. [15] [16] [17] Limits of normal as the predicted Ϯ 20% can only be accurate when the variance above and below the predicted regression line is proportional with the predicted value (ie, heteroscedastic: large variance with large values and small variance with small values). However, since this is not the case, because the scatter around the predicted regression line is constant (homoscedastic) in pulmonary function measurements, the 80% predicted rule of thumb may lead to false-positive diagnosis in the elderly and shorter individuals with smaller predicted values and underdiagnosis in younger and taller patients with larger predicted values. [15] [16] [17] Misdiagnosis of pulmonary function abnormalities by the conventional cutoff values may have interfered with the interpretation of prior research aiming to investigate the impact of heart failure and several clinical variables on pulmonary function. This may explain part of the inconsistencies across the studies. In fact, a smoking history of Ն10 pack-years was a significant predictor of diffusion impairment and airway obstruction using the lower limit of normal criterion but not using the conventional cutoff values. This implies that inclusion of subjects who are incorrectly labeled as having pulmonary dysfunction distorted the effect of smoking on pulmonary function. Indeed, lowering the conventional cutoff values to match the more stringent lower limit of normal and thus avoid overdiagnosis of diffusion impairment and airway obstruction in the elderly produced similar results as the lower limit of normal. Similarly, female sex was an independent predictor of diffusion impairment according to the lower limit of normal but not according to the 80% predicted value. However, decreasing the cutoff point to define diffusion impairment showed findings comparable to the lower limit of normal. On the other hand, by increasing the lower limit of normal to the 10th percentile, the association between female sex and diffusion impairment was lost (data not shown). This is explained by the fact that the lower ranges of diffusing capacity represented relatively more women than men. In summary, the lower limit of normal criterion identified more predictors of diffusion impairment and airway obstruction compared with conventional cutoff values in subjects with chronic heart failure with left ventricular systolic dysfunction. However, when conventional cutoff points were lowered to match the more stringent lower limit of normal criterion, the same effects were seen.
The effect of different definitions has also been put forward in the study of de Marco et al, 25 who have shown that the role of age, sex, former smoking, and low BMI on the development of COPD differs according to the definition used to define COPD. They suggested the need for a definition of COPD that is not exclusively based on spirometry.
Little is known about the clinical impact of different criteria of pulmonary dysfunction. Mannino and DiazGuzman 26 followed up the mortality data of a large number of subjects from the National Health and Nutrition Examination Survey III classified as normal, obstructed, or restricted using conventional cutoff values and the lower limit of normal. They found that subjects classified as normal using the lower limit of normal but obstructed or restricted using conventional cutoff values had a higher risk of mortality than normal subjects in up to 18 y of follow-up. This finding suggests that conventional criteria may identify at-risk patients who would have been missed using the lower limit of normal. This study was limited by the lack of post-bronchodilator pulmonary function test results, outcome parameters other than mortality, and the lack of comparison between subjects with mild airway obstruction according to conventional cutoff values (FEV 1 /FVC Ͻ0.7 and FEV 1 Ն80% predicted) and normal subjects according to the lower limit of normal (FEV 1 /FVC, FEV 1 , and FVC Նlower limit of normal). More longitudinal studies are warranted to determine which criterion is clinically more relevant in terms of morbidity (symptoms, exercise tolerance, health-related quality of life, hospitalization, use of health recourses) and mortality. Since we did not follow our subjects prospectively, it remains unknown whether pulmonary function impairment had prognostic implications in our study population and whether this is influenced by different definitions of pulmonary dysfunction. Several factors have been implied to play a role in the etiology of pulmonary function impairment in patients with heart failure, including the effects of heart failure itself on pulmonary function in addition to (previously undiagnosed) underlying pulmonary disease and confounding influences, such as smoking, coronary artery bypass grafting, and obesity. [4] [5] [6] [7] 13 Diffusion impairment has been thought to be related to the thickening of the alveolar-capillary membrane due to hydrostatic mechanical injury, interstitial edema, remodeling, and fibrosis. 1, 2, [4] [5] [6] 27 Because heart transplantation does not affect or may even worsen pulmonary diffusing capacity despite an improvement in hemodynamic status and lung volumes, 28 it has been suggested that reduced diffusing capacity in chronic heart failure may be related to permanent damage to the alveolar-capillary membrane. 2 Other possible causes of diffusion impairment in heart failure include reduced lung and pulmonary capillary blood volumes, ventilation-perfusion mismatch, recurrent pulmonary emboli, smoking, and cardiopulmonary bypass. [4] [5] [6] 13 The results of our study showed a higher NYHA class, smoking of Ն10 pack-years, pulmonary congestion, pleural effusion, and cardiomegaly to be associated with more impaired diffusing capacity, the latter 3 probably due to their negative effects on lung volume. Indeed, diffusing capacity corrected for V A was not significantly different between the groups. Also, although V A turned out to be an independent predictor of diffusion impairment, pulmonary congestion and cardiomegaly were not. In contrast to previous reports, [29] [30] [31] the use of angiotensin-converting enzyme inhibitors and aldosterone antagonists was not associated with increased diffusing capacity. Also, diffusing capacity was not significantly different between groups of subjects with or without a history of coronary artery bypass grafting. Independent predictors of diffusion impairment were BMI, pack-years (continuous variable), and V A , whereas the role of sex and of having smoked Ն10 packyears depended on the definition used to define diffusion impairment. Although the underlying mechanisms are not clear, women seemed to be more sensitive to the detrimental effects of heart failure on diffusing capacity. Sex differences in pulmonary function have been recognized before but not specifically in the heart failure population. Adult women have been reported to have lower resting lung diffusing capacity corrected for hemoglobin, smaller lung volumes, and lower maximal expiratory flows, even when corrected for age and standing height relative to men. 32 It has been suggested that these sex differences in part can be explained by pulmonary structural differences (fewer total number of alveoli and smaller airway diameter relative to lung size) and hormonal influences in women. 32 More research is needed regarding the influence of sex on pulmonary function in general and specifically in the heart failure population. The protective association between a higher BMI and less likelihood of having diffusion impairment has not, to our knowledge, been described before in subjects with chronic heart failure. However, some studies in healthy obese non-smokers have suggested that diffusing capacity may be increased in extremely obese subjects, probably as a result of the increase in blood volume. 33 Restriction has been linked to cardiomegaly, pleural effusion, respiratory muscle weakness, coronary artery bypass grafting, fibrosis from chronic congestion, and reduced lung compliance due to chronic vascular engorgement, interstitial/alveolar fluid accumulation, and chronic remodeling of the pulmonary vasculature due to elevated left atrial pressure. 1, [4] [5] [6] 13, 34, 35 In line with expectations, we found lung volumes to be lower in subjects with pulmonary congestion, pleural effusion, cardiomegaly, and a history of coronary artery bypass grafting.
Airway obstruction has been attributed to alveolar fluid accumulation, bronchial mucosal swelling, peribronchial edema and fibrosis, squamous metaplasia of bronchial epithelial cells induced by transforming growth factor-␤ from the failing heart, geometric decrease in airway size from reduction in lung volume, abnormalities of autonomic control, neurohumoral bronchoconstriction, bronchial hyperresponsiveness, and smoking, 4-7,13,36 although results are not consistent. 14 Our study showed a greater impaired FEV 1 /VC ratio in subjects who had smoked Ն10 packyears. Also, having smoked Ն10 pack-years was a significant predictor of airway obstruction, but this depended on the definition used to define airway obstruction. Although we excluded patients with known COPD or other obstructive lung disease, we cannot rule out the possibility that some of the subjects with airway obstruction had previously undiagnosed COPD, because most subjects were current or former smokers. In fact, 16% (lower limit of normal) to 24% (conventional cutoff values) of the subjects had post-bronchodilator airway obstruction after inhaling 400 g salbutamol and 80 g atrovent. These subjects had more symptoms of cough and sputum than those without post-bronchodilator airway obstruction (data not shown). Also, subjects who were current or former smokers tended more often to have post-bronchodilator airway obstruction than those who had never smoked (lower limit of normal: 19% vs 6%, P ϭ .06; conventional cutoff values: 27% vs 11%, P ϭ .05). However, hyperinflation, which has been found to be a valid indicator of true COPD in patients with congestive heart failure, 37 was not significantly different between groups of subjects with persistent airway obstruction after bronchodilation and those with reversible airway obstruction (data not shown). Although airway obstruction in heart failure has also been attributed to pulmonary congestion, the FEV 1 /VC ratio was not significantly different between groups of subjects with and without pulmonary congestion in our study, which does not exclude the contribution of pulmonary congestion to small airway obstruction.
Importantly, airway obstruction may lead to hyperinflation of the lungs due to expiratory flow limitation and air trapping, which was found in almost half of our subjects with airway obstruction as defined by an increased residual volume/TLC ratio. This may contribute to symptoms of dyspnea, poor exercise tolerance, increased work of breathing and oxygen consumption, respiratory muscle dysfunction, and adverse impact on cardiac function by decreasing the preload. 38 Thus, irrespective of the causes, pulmonary function abnormalities associated with chronic heart failure may explain part of the symptoms and functional disability encountered in these subjects. [8] [9] [10] [11] [12] Moreover, pulmonary function impairment increases with the severity of heart failure, 9,11 provides important prognostic information, [39] [40] [41] [42] and may ameliorate or normalize with several treatment modalities, such as pharmacologic and non-pharmacologic treatment of heart failure 2,28,43-46 and anti-obstructive therapy with bronchodilators. [47] [48] [49] [50] [51] [52] [53] Pulmonary function might thus be used as a guide for the evaluation of patients with chronic heart failure, with respect to severity of disease, prognosis, and response to treatment.
Some limitations of this study deserve further discussion. It is important to realize that these results may not be applicable to all patients with chronic heart failure, since we did not include subjects with preserved systolic function, who seem to have less impaired pulmonary function. 54 Furthermore, patients with more severe heart failure could have been underrepresented in this study because of an inability to participate, and thus pulmonary function abnormalities might have been underestimated. Finally, considering the relatively small number of subjects included in the current study, in particular women and nonsmokers, further research is needed to confirm our results.
Conclusions
In conclusion, the lower limit of normal identifies sex as an extra predictor of diffusion impairment and a smoking history of Ն10 pack-years as an additional predictor of both diffusion impairment and airway obstruction compared with conventional cutoff values in subjects with chronic heart failure with left ventricular systolic dysfunction. However, when conventional cutoff points were lowered to match the more stringent lower limit of normal criterion, the same effects were seen. Our results stress the need for clear definitions of pulmonary function abnormalities. More longitudinal studies are warranted to determine which criterion is clinically more relevant. Specifically, future research should focus on better characterizing the potentially misclassified group of patients who are above the lower limit of normal but below the conventional cutoff values. Do these patients have a worse outcome with higher morbidity and mortality rates that is amenable to treatment, or do they present with clinical features similar to those with chronic heart failure but without pulmonary dysfunction? Finally, more research is needed regarding the influence of sex on pulmonary function in the heart failure population and the possible underlying pathophysiologic mechanisms.
